Due to the COVID-19 pandemic, the global Intravenous (IV) Ibuprofen market size is estimated to be worth US$ 8103.3 million in 2022 and is forecast to a readjusted size of US$ 15400 million by 2028 with a Compound Annual Growth Rate (CAGR) of 11.3% during the forecast period. Intravenous (IV) ibuprofen is a non-steroidal anti-inflammatory drug (NSAID) used to reduce or treat pain, fever, and inflammation occurred due to disease, operative procedures or trauma, and acute illness.

Intravenous_Ibuprofen_Market

Fully considering the economic change by this health crisis, 100 mg Dose accounting for % of the Intravenous (IV) Ibuprofen global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

As for the Europe Intravenous (IV) Ibuprofen landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.

The global key manufacturers of Intravenous (IV) Ibuprofen include Cumberland Pharmaceuticals, Alveda Pharmaceuticals, CSL Limited, Sandor Medicaids, PT. Soho Industri Pharmasi, Germin MED, Grifols, Gloria Pharmaceuticals and Al Nabeel International, etc. In 2021, the global top five players have a share of approximately % in terms of revenue.

Intravenous (IV) Ibuprofen Market Segment Review

Intravenous (IV) Ibuprofen market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Intravenous (IV) Ibuprofen market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.

Intravenous (IV) Ibuprofen Market by Type

100 mg Dose
200 mg Dose
400 mg Dose
800 mg Dose

Intravenous (IV) Ibuprofen Market by Application

Pain
Fever
Inflammation

Major Players in the Intravenous (IV) Ibuprofen Market

Cumberland Pharmaceuticals
Alveda Pharmaceuticals
CSL Limited
Sandor Medicaids
PT. Soho Industri Pharmasi
Germin MED
Grifols
Gloria Pharmaceuticals
Al Nabeel International
Laboratorios Valmorca

Intravenous (IV) Ibuprofen Market by Region

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

Intravenous (IV) Ibuprofen Market Report Coverage

Report Metric	Details
Base Year:	2021
Market Size in 2022:	USD 8103.3 Million
Forecast Period:	2022 to 2028
Forecast Period 2022 to 2028 CAGR:	11.3%
2028 Value Projection:	USD 15400 Million
No. of Pages:	113
Tables & Figures	134
Segments covered:	Type, Application, Region

Frequently Asked Questions About This Report

1. What is the current size of the global Intravenous (IV) Ibuprofen Market?

Ans. The global Intravenous (IV) Ibuprofen market size is estimated to be worth US$ 8103.3 million in 2022 and is forecast to a readjusted size of US$ 15400 million by 2028 with a Compound Annual Growth Rate (CAGR) of 11.3% during the forecast period.

2. Who are the major companies in the Intravenous (IV) Ibuprofen Market?

Ans. Major companies across the market are Cumberland Pharmaceuticals, Alveda Pharmaceuticals, CSL Limited, Sandor Medicaids, PT. Soho Industri Pharmasi, Germin MED, Grifols S A, Gloria Pharmaceuticals, Al Nabeel International, Laboratorios Valmorca, Others, are positively contributing to the global market forecast.

3. What would be the forecast period in the Intravenous (IV) Ibuprofen Market report?

Ans. The forecast period in the Intravenous (IV) Ibuprofen Market report is from 2022-2028

4. How can I get sample report/company profiles of the global Intravenous (IV) Ibuprofen industry?

Ans. The sample for the global Intravenous (IV) Ibuprofen market report can be obtained on demand from the Valuates Reports website. Also, 24*7 chat support and direct call services are provided to procure the sample report.

1 Study Coverage

1.1 Intravenous (IV) Ibuprofen Product Introduction

1.2 Market by Type

1.2.1 Global Intravenous (IV) Ibuprofen Market Size Growth Rate by Type, 2017 VS 2021 VS 2028

1.2.2 100 mg Dose

1.2.3 200 mg Dose

1.2.4 400 mg Dose

1.2.5 800 mg Dose

1.3 Market by Application

1.3.1 Global Intravenous (IV) Ibuprofen Market Size Growth Rate by Application, 2017 VS 2021 VS 2028

1.3.2 Pain

1.3.3 Fever

1.3.4 Inflammation

1.4 Study Objectives

1.5 Years Considered

2 Executive Summary

2.1 Global Intravenous (IV) Ibuprofen Sales Estimates and Forecasts 2017-2028

2.2 Global Intravenous (IV) Ibuprofen Revenue Estimates and Forecasts 2017-2028

2.3 Global Intravenous (IV) Ibuprofen Revenue by Region: 2017 VS 2021 VS 2028

2.4 Global Intravenous (IV) Ibuprofen Sales by Region

2.4.1 Global Intravenous (IV) Ibuprofen Sales by Region (2017-2022)

2.4.2 Global Sales Intravenous (IV) Ibuprofen by Region (2023-2028)

2.5 Global Intravenous (IV) Ibuprofen Revenue by Region

2.5.1 Global Intravenous (IV) Ibuprofen Revenue by Region (2017-2022)

2.5.2 Global Intravenous (IV) Ibuprofen Revenue by Region (2023-2028)

2.6 North America

2.7 Europe

2.8 Asia-Pacific

2.9 Latin America

2.10 Middle East & Africa

3 Competition by Manufacturers

3.1 Global Intravenous (IV) Ibuprofen Sales by Manufacturers

3.1.1 Global Top Intravenous (IV) Ibuprofen Manufacturers by Sales (2017-2022)

3.1.2 Global Intravenous (IV) Ibuprofen Sales Market Share by Manufacturers (2017-2022)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Intravenous (IV) Ibuprofen in 2021

3.2 Global Intravenous (IV) Ibuprofen Revenue by Manufacturers

3.2.1 Global Intravenous (IV) Ibuprofen Revenue by Manufacturers (2017-2022)

3.2.2 Global Intravenous (IV) Ibuprofen Revenue Market Share by Manufacturers (2017-2022)

3.2.3 Global Top 10 and Top 5 Companies by Intravenous (IV) Ibuprofen Revenue in 2021

3.3 Global Intravenous (IV) Ibuprofen Sales Price by Manufacturers (2017-2022)

3.4 Analysis of Competitive Landscape

3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Intravenous (IV) Ibuprofen Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.4.3 Global Intravenous (IV) Ibuprofen Manufacturers Geographical Distribution

3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global Intravenous (IV) Ibuprofen Sales by Type

4.1.1 Global Intravenous (IV) Ibuprofen Historical Sales by Type (2017-2022)

4.1.2 Global Intravenous (IV) Ibuprofen Forecasted Sales by Type (2023-2028)

4.1.3 Global Intravenous (IV) Ibuprofen Sales Market Share by Type (2017-2028)

4.2 Global Intravenous (IV) Ibuprofen Revenue by Type

4.2.1 Global Intravenous (IV) Ibuprofen Historical Revenue by Type (2017-2022)

4.2.2 Global Intravenous (IV) Ibuprofen Forecasted Revenue by Type (2023-2028)

4.2.3 Global Intravenous (IV) Ibuprofen Revenue Market Share by Type (2017-2028)

4.3 Global Intravenous (IV) Ibuprofen Price by Type

4.3.1 Global Intravenous (IV) Ibuprofen Price by Type (2017-2022)

4.3.2 Global Intravenous (IV) Ibuprofen Price Forecast by Type (2023-2028)

5 Market Size by Application

5.1 Global Intravenous (IV) Ibuprofen Sales by Application

5.1.1 Global Intravenous (IV) Ibuprofen Historical Sales by Application (2017-2022)

5.1.2 Global Intravenous (IV) Ibuprofen Forecasted Sales by Application (2023-2028)

5.1.3 Global Intravenous (IV) Ibuprofen Sales Market Share by Application (2017-2028)

5.2 Global Intravenous (IV) Ibuprofen Revenue by Application

5.2.1 Global Intravenous (IV) Ibuprofen Historical Revenue by Application (2017-2022)

5.2.2 Global Intravenous (IV) Ibuprofen Forecasted Revenue by Application (2023-2028)

5.2.3 Global Intravenous (IV) Ibuprofen Revenue Market Share by Application (2017-2028)

5.3 Global Intravenous (IV) Ibuprofen Price by Application

5.3.1 Global Intravenous (IV) Ibuprofen Price by Application (2017-2022)

5.3.2 Global Intravenous (IV) Ibuprofen Price Forecast by Application (2023-2028)

6 North America

6.1 North America Intravenous (IV) Ibuprofen Market Size by Type

6.1.1 North America Intravenous (IV) Ibuprofen Sales by Type (2017-2028)

6.1.2 North America Intravenous (IV) Ibuprofen Revenue by Type (2017-2028)

6.2 North America Intravenous (IV) Ibuprofen Market Size by Application

6.2.1 North America Intravenous (IV) Ibuprofen Sales by Application (2017-2028)

6.2.2 North America Intravenous (IV) Ibuprofen Revenue by Application (2017-2028)

6.3 North America Intravenous (IV) Ibuprofen Market Size by Country

6.3.1 North America Intravenous (IV) Ibuprofen Sales by Country (2017-2028)

6.3.2 North America Intravenous (IV) Ibuprofen Revenue by Country (2017-2028)

6.3.3 U.S.

6.3.4 Canada

7 Europe

7.1 Europe Intravenous (IV) Ibuprofen Market Size by Type

7.1.1 Europe Intravenous (IV) Ibuprofen Sales by Type (2017-2028)

7.1.2 Europe Intravenous (IV) Ibuprofen Revenue by Type (2017-2028)

7.2 Europe Intravenous (IV) Ibuprofen Market Size by Application

7.2.1 Europe Intravenous (IV) Ibuprofen Sales by Application (2017-2028)

7.2.2 Europe Intravenous (IV) Ibuprofen Revenue by Application (2017-2028)

7.3 Europe Intravenous (IV) Ibuprofen Market Size by Country

7.3.1 Europe Intravenous (IV) Ibuprofen Sales by Country (2017-2028)

7.3.2 Europe Intravenous (IV) Ibuprofen Revenue by Country (2017-2028)

7.3.3 Germany

7.3.4 France

7.3.5 U.K.

7.3.6 Italy

7.3.7 Russia

8 Asia Pacific

8.1 Asia Pacific Intravenous (IV) Ibuprofen Market Size by Type

8.1.1 Asia Pacific Intravenous (IV) Ibuprofen Sales by Type (2017-2028)

8.1.2 Asia Pacific Intravenous (IV) Ibuprofen Revenue by Type (2017-2028)

8.2 Asia Pacific Intravenous (IV) Ibuprofen Market Size by Application

8.2.1 Asia Pacific Intravenous (IV) Ibuprofen Sales by Application (2017-2028)

8.2.2 Asia Pacific Intravenous (IV) Ibuprofen Revenue by Application (2017-2028)

8.3 Asia Pacific Intravenous (IV) Ibuprofen Market Size by Region

8.3.1 Asia Pacific Intravenous (IV) Ibuprofen Sales by Region (2017-2028)

8.3.2 Asia Pacific Intravenous (IV) Ibuprofen Revenue by Region (2017-2028)

8.3.3 China

8.3.4 Japan

8.3.5 South Korea

8.3.6 India

8.3.7 Australia

8.3.8 Taiwan

8.3.9 Indonesia

8.3.10 Thailand

8.3.11 Malaysia

8.3.12 Philippines

9 Latin America

9.1 Latin America Intravenous (IV) Ibuprofen Market Size by Type

9.1.1 Latin America Intravenous (IV) Ibuprofen Sales by Type (2017-2028)

9.1.2 Latin America Intravenous (IV) Ibuprofen Revenue by Type (2017-2028)

9.2 Latin America Intravenous (IV) Ibuprofen Market Size by Application

9.2.1 Latin America Intravenous (IV) Ibuprofen Sales by Application (2017-2028)

9.2.2 Latin America Intravenous (IV) Ibuprofen Revenue by Application (2017-2028)

9.3 Latin America Intravenous (IV) Ibuprofen Market Size by Country

9.3.1 Latin America Intravenous (IV) Ibuprofen Sales by Country (2017-2028)

9.3.2 Latin America Intravenous (IV) Ibuprofen Revenue by Country (2017-2028)

9.3.3 Mexico

9.3.4 Brazil

9.3.5 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Intravenous (IV) Ibuprofen Market Size by Type

10.1.1 Middle East and Africa Intravenous (IV) Ibuprofen Sales by Type (2017-2028)

10.1.2 Middle East and Africa Intravenous (IV) Ibuprofen Revenue by Type (2017-2028)

10.2 Middle East and Africa Intravenous (IV) Ibuprofen Market Size by Application

10.2.1 Middle East and Africa Intravenous (IV) Ibuprofen Sales by Application (2017-2028)

10.2.2 Middle East and Africa Intravenous (IV) Ibuprofen Revenue by Application (2017-2028)

10.3 Middle East and Africa Intravenous (IV) Ibuprofen Market Size by Country

10.3.1 Middle East and Africa Intravenous (IV) Ibuprofen Sales by Country (2017-2028)

10.3.2 Middle East and Africa Intravenous (IV) Ibuprofen Revenue by Country (2017-2028)

10.3.3 Turkey

10.3.4 Saudi Arabia

11 Company Profiles

11.1 Cumberland Pharmaceuticals

11.1.1 Cumberland Pharmaceuticals Corporation Information

11.1.2 Cumberland Pharmaceuticals Overview

11.1.3 Cumberland Pharmaceuticals Intravenous (IV) Ibuprofen Sales, Price, Revenue and Gross Margin (2017-2022)

11.1.4 Cumberland Pharmaceuticals Intravenous (IV) Ibuprofen Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 Cumberland Pharmaceuticals Recent Developments

11.2 Alveda Pharmaceuticals

11.2.1 Alveda Pharmaceuticals Corporation Information

11.2.2 Alveda Pharmaceuticals Overview

11.2.3 Alveda Pharmaceuticals Intravenous (IV) Ibuprofen Sales, Price, Revenue and Gross Margin (2017-2022)

11.2.4 Alveda Pharmaceuticals Intravenous (IV) Ibuprofen Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 Alveda Pharmaceuticals Recent Developments

11.3 CSL Limited

11.3.1 CSL Limited Corporation Information

11.3.2 CSL Limited Overview

11.3.3 CSL Limited Intravenous (IV) Ibuprofen Sales, Price, Revenue and Gross Margin (2017-2022)

11.3.4 CSL Limited Intravenous (IV) Ibuprofen Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 CSL Limited Recent Developments

11.4 Sandor Medicaids

11.4.1 Sandor Medicaids Corporation Information

11.4.2 Sandor Medicaids Overview

11.4.3 Sandor Medicaids Intravenous (IV) Ibuprofen Sales, Price, Revenue and Gross Margin (2017-2022)

11.4.4 Sandor Medicaids Intravenous (IV) Ibuprofen Product Model Numbers, Pictures, Descriptions and Specifications

11.4.5 Sandor Medicaids Recent Developments

11.5 PT. Soho Industri Pharmasi

11.5.1 PT. Soho Industri Pharmasi Corporation Information

11.5.2 PT. Soho Industri Pharmasi Overview

11.5.3 PT. Soho Industri Pharmasi Intravenous (IV) Ibuprofen Sales, Price, Revenue and Gross Margin (2017-2022)

11.5.4 PT. Soho Industri Pharmasi Intravenous (IV) Ibuprofen Product Model Numbers, Pictures, Descriptions and Specifications

11.5.5 PT. Soho Industri Pharmasi Recent Developments

11.6 Germin MED

11.6.1 Germin MED Corporation Information

11.6.2 Germin MED Overview

11.6.3 Germin MED Intravenous (IV) Ibuprofen Sales, Price, Revenue and Gross Margin (2017-2022)

11.6.4 Germin MED Intravenous (IV) Ibuprofen Product Model Numbers, Pictures, Descriptions and Specifications

11.6.5 Germin MED Recent Developments

11.7 Grifols

11.7.1 Grifols Corporation Information

11.7.2 Grifols Overview

11.7.3 Grifols Intravenous (IV) Ibuprofen Sales, Price, Revenue and Gross Margin (2017-2022)

11.7.4 Grifols Intravenous (IV) Ibuprofen Product Model Numbers, Pictures, Descriptions and Specifications

11.7.5 Grifols Recent Developments

11.8 Gloria Pharmaceuticals

11.8.1 Gloria Pharmaceuticals Corporation Information

11.8.2 Gloria Pharmaceuticals Overview

11.8.3 Gloria Pharmaceuticals Intravenous (IV) Ibuprofen Sales, Price, Revenue and Gross Margin (2017-2022)

11.8.4 Gloria Pharmaceuticals Intravenous (IV) Ibuprofen Product Model Numbers, Pictures, Descriptions and Specifications

11.8.5 Gloria Pharmaceuticals Recent Developments

11.9 Al Nabeel International

11.9.1 Al Nabeel International Corporation Information

11.9.2 Al Nabeel International Overview

11.9.3 Al Nabeel International Intravenous (IV) Ibuprofen Sales, Price, Revenue and Gross Margin (2017-2022)

11.9.4 Al Nabeel International Intravenous (IV) Ibuprofen Product Model Numbers, Pictures, Descriptions and Specifications

11.9.5 Al Nabeel International Recent Developments

11.10 Laboratorios Valmorca

11.10.1 Laboratorios Valmorca Corporation Information

11.10.2 Laboratorios Valmorca Overview

11.10.3 Laboratorios Valmorca Intravenous (IV) Ibuprofen Sales, Price, Revenue and Gross Margin (2017-2022)

11.10.4 Laboratorios Valmorca Intravenous (IV) Ibuprofen Product Model Numbers, Pictures, Descriptions and Specifications

11.10.5 Laboratorios Valmorca Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 Intravenous (IV) Ibuprofen Industry Chain Analysis

12.2 Intravenous (IV) Ibuprofen Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Intravenous (IV) Ibuprofen Production Mode & Process

12.4 Intravenous (IV) Ibuprofen Sales and Marketing

12.4.1 Intravenous (IV) Ibuprofen Sales Channels

12.4.2 Intravenous (IV) Ibuprofen Distributors

12.5 Intravenous (IV) Ibuprofen Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

13.1 Intravenous (IV) Ibuprofen Industry Trends

13.2 Intravenous (IV) Ibuprofen Market Drivers

13.3 Intravenous (IV) Ibuprofen Market Challenges

13.4 Intravenous (IV) Ibuprofen Market Restraints

14 Key Findings in The Global Intravenous (IV) Ibuprofen Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

FEATURED COMPANIES

Cumberland Pharmaceuticals

Alveda Pharmaceuticals

CSL Limited

Sandor Medicaids

PT. Soho Industri Pharmasi

Germin MED

Grifols S A

Gloria Pharmaceuticals

Al Nabeel International

Laboratorios Valmorca

List of Tables

Table 1. Global Intravenous (IV) Ibuprofen Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)

Table 2. Major Manufacturers of 100 mg Dose

Table 3. Major Manufacturers of 200 mg Dose

Table 4. Major Manufacturers of 400 mg Dose

Table 5. Major Manufacturers of 800 mg Dose

Table 6. Global Intravenous (IV) Ibuprofen Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)

Table 7. Global Intravenous (IV) Ibuprofen Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)

Table 8. Global Intravenous (IV) Ibuprofen Sales by Region (2017-2022) & (MT)

Table 9. Global Intravenous (IV) Ibuprofen Sales Market Share by Region (2017-2022)

Table 10. Global Intravenous (IV) Ibuprofen Sales by Region (2023-2028) & (MT)

Table 11. Global Intravenous (IV) Ibuprofen Sales Market Share by Region (2023-2028)

Table 12. Global Intravenous (IV) Ibuprofen Revenue by Region (2017-2022) & (US$ Million)

Table 13. Global Intravenous (IV) Ibuprofen Revenue Market Share by Region (2017-2022)

Table 14. Global Intravenous (IV) Ibuprofen Revenue by Region (2023-2028) & (US$ Million)

Table 15. Global Intravenous (IV) Ibuprofen Revenue Market Share by Region (2023-2028)

Table 16. Global Intravenous (IV) Ibuprofen Sales by Manufacturers (2017-2022) & (MT)

Table 17. Global Intravenous (IV) Ibuprofen Sales Share by Manufacturers (2017-2022)

Table 18. Global Intravenous (IV) Ibuprofen Revenue by Manufacturers (2017-2022) & (US$ Million)

Table 19. Global Intravenous (IV) Ibuprofen Revenue Share by Manufacturers (2017-2022)

Table 20. Intravenous (IV) Ibuprofen Price by Manufacturers (2017-2022) &(USD/Kg)

Table 21. Global Intravenous (IV) Ibuprofen Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 22. Global Intravenous (IV) Ibuprofen by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intravenous (IV) Ibuprofen as of 2021)

Table 23. Intravenous (IV) Ibuprofen Manufacturing Base Distribution and Headquarters

Table 24. Manufacturers Intravenous (IV) Ibuprofen Product Offered

Table 25. Date of Manufacturers Enter into Intravenous (IV) Ibuprofen Market

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. Global Intravenous (IV) Ibuprofen Sales by Type (2017-2022) & (MT)

Table 28. Global Intravenous (IV) Ibuprofen Sales by Type (2023-2028) & (MT)

Table 29. Global Intravenous (IV) Ibuprofen Sales Share by Type (2017-2022)

Table 30. Global Intravenous (IV) Ibuprofen Sales Share by Type (2023-2028)

Table 31. Global Intravenous (IV) Ibuprofen Revenue by Type (2017-2022) & (US$ Million)

Table 32. Global Intravenous (IV) Ibuprofen Revenue by Type (2023-2028) & (US$ Million)

Table 33. Global Intravenous (IV) Ibuprofen Revenue Share by Type (2017-2022)

Table 34. Global Intravenous (IV) Ibuprofen Revenue Share by Type (2023-2028)

Table 35. Intravenous (IV) Ibuprofen Price by Type (2017-2022) & (USD/Kg)

Table 36. Global Intravenous (IV) Ibuprofen Price Forecast by Type (2023-2028) & (USD/Kg)

Table 37. Global Intravenous (IV) Ibuprofen Sales by Application (2017-2022) & (MT)

Table 38. Global Intravenous (IV) Ibuprofen Sales by Application (2023-2028) & (MT)

Table 39. Global Intravenous (IV) Ibuprofen Sales Share by Application (2017-2022)

Table 40. Global Intravenous (IV) Ibuprofen Sales Share by Application (2023-2028)

Table 41. Global Intravenous (IV) Ibuprofen Revenue by Application (2017-2022) & (US$ Million)

Table 42. Global Intravenous (IV) Ibuprofen Revenue by Application (2023-2028) & (US$ Million)

Table 43. Global Intravenous (IV) Ibuprofen Revenue Share by Application (2017-2022)

Table 44. Global Intravenous (IV) Ibuprofen Revenue Share by Application (2023-2028)

Table 45. Intravenous (IV) Ibuprofen Price by Application (2017-2022) & (USD/Kg)

Table 46. Global Intravenous (IV) Ibuprofen Price Forecast by Application (2023-2028) & (USD/Kg)

Table 47. North America Intravenous (IV) Ibuprofen Sales by Type (2017-2022) & (MT)

Table 48. North America Intravenous (IV) Ibuprofen Sales by Type (2023-2028) & (MT)

Table 49. North America Intravenous (IV) Ibuprofen Revenue by Type (2017-2022) & (US$ Million)

Table 50. North America Intravenous (IV) Ibuprofen Revenue by Type (2023-2028) & (US$ Million)

Table 51. North America Intravenous (IV) Ibuprofen Sales by Application (2017-2022) & (MT)

Table 52. North America Intravenous (IV) Ibuprofen Sales by Application (2023-2028) & (MT)

Table 53. North America Intravenous (IV) Ibuprofen Revenue by Application (2017-2022) & (US$ Million)

Table 54. North America Intravenous (IV) Ibuprofen Revenue by Application (2023-2028) & (US$ Million)

Table 55. North America Intravenous (IV) Ibuprofen Sales by Country (2017-2022) & (MT)

Table 56. North America Intravenous (IV) Ibuprofen Sales by Country (2023-2028) & (MT)

Table 57. North America Intravenous (IV) Ibuprofen Revenue by Country (2017-2022) & (US$ Million)

Table 58. North America Intravenous (IV) Ibuprofen Revenue by Country (2023-2028) & (US$ Million)

Table 59. Europe Intravenous (IV) Ibuprofen Sales by Type (2017-2022) & (MT)

Table 60. Europe Intravenous (IV) Ibuprofen Sales by Type (2023-2028) & (MT)

Table 61. Europe Intravenous (IV) Ibuprofen Revenue by Type (2017-2022) & (US$ Million)

Table 62. Europe Intravenous (IV) Ibuprofen Revenue by Type (2023-2028) & (US$ Million)

Table 63. Europe Intravenous (IV) Ibuprofen Sales by Application (2017-2022) & (MT)

Table 64. Europe Intravenous (IV) Ibuprofen Sales by Application (2023-2028) & (MT)

Table 65. Europe Intravenous (IV) Ibuprofen Revenue by Application (2017-2022) & (US$ Million)

Table 66. Europe Intravenous (IV) Ibuprofen Revenue by Application (2023-2028) & (US$ Million)

Table 67. Europe Intravenous (IV) Ibuprofen Sales by Country (2017-2022) & (MT)

Table 68. Europe Intravenous (IV) Ibuprofen Sales by Country (2023-2028) & (MT)

Table 69. Europe Intravenous (IV) Ibuprofen Revenue by Country (2017-2022) & (US$ Million)

Table 70. Europe Intravenous (IV) Ibuprofen Revenue by Country (2023-2028) & (US$ Million)

Table 71. Asia Pacific Intravenous (IV) Ibuprofen Sales by Type (2017-2022) & (MT)

Table 72. Asia Pacific Intravenous (IV) Ibuprofen Sales by Type (2023-2028) & (MT)

Table 73. Asia Pacific Intravenous (IV) Ibuprofen Revenue by Type (2017-2022) & (US$ Million)

Table 74. Asia Pacific Intravenous (IV) Ibuprofen Revenue by Type (2023-2028) & (US$ Million)

Table 75. Asia Pacific Intravenous (IV) Ibuprofen Sales by Application (2017-2022) & (MT)

Table 76. Asia Pacific Intravenous (IV) Ibuprofen Sales by Application (2023-2028) & (MT)

Table 77. Asia Pacific Intravenous (IV) Ibuprofen Revenue by Application (2017-2022) & (US$ Million)

Table 78. Asia Pacific Intravenous (IV) Ibuprofen Revenue by Application (2023-2028) & (US$ Million)

Table 79. Asia Pacific Intravenous (IV) Ibuprofen Sales by Region (2017-2022) & (MT)

Table 80. Asia Pacific Intravenous (IV) Ibuprofen Sales by Region (2023-2028) & (MT)

Table 81. Asia Pacific Intravenous (IV) Ibuprofen Revenue by Region (2017-2022) & (US$ Million)

Table 82. Asia Pacific Intravenous (IV) Ibuprofen Revenue by Region (2023-2028) & (US$ Million)

Table 83. Latin America Intravenous (IV) Ibuprofen Sales by Type (2017-2022) & (MT)

Table 84. Latin America Intravenous (IV) Ibuprofen Sales by Type (2023-2028) & (MT)

Table 85. Latin America Intravenous (IV) Ibuprofen Revenue by Type (2017-2022) & (US$ Million)

Table 86. Latin America Intravenous (IV) Ibuprofen Revenue by Type (2023-2028) & (US$ Million)

Table 87. Latin America Intravenous (IV) Ibuprofen Sales by Application (2017-2022) & (MT)

Table 88. Latin America Intravenous (IV) Ibuprofen Sales by Application (2023-2028) & (MT)

Table 89. Latin America Intravenous (IV) Ibuprofen Revenue by Application (2017-2022) & (US$ Million)

Table 90. Latin America Intravenous (IV) Ibuprofen Revenue by Application (2023-2028) & (US$ Million)

Table 91. Latin America Intravenous (IV) Ibuprofen Sales by Country (2017-2022) & (MT)

Table 92. Latin America Intravenous (IV) Ibuprofen Sales by Country (2023-2028) & (MT)

Table 93. Latin America Intravenous (IV) Ibuprofen Revenue by Country (2017-2022) & (US$ Million)

Table 94. Latin America Intravenous (IV) Ibuprofen Revenue by Country (2023-2028) & (US$ Million)

Table 95. Middle East and Africa Intravenous (IV) Ibuprofen Sales by Type (2017-2022) & (MT)

Table 96. Middle East and Africa Intravenous (IV) Ibuprofen Sales by Type (2023-2028) & (MT)

Table 97. Middle East and Africa Intravenous (IV) Ibuprofen Revenue by Type (2017-2022) & (US$ Million)

Table 98. Middle East and Africa Intravenous (IV) Ibuprofen Revenue by Type (2023-2028) & (US$ Million)

Table 99. Middle East and Africa Intravenous (IV) Ibuprofen Sales by Application (2017-2022) & (MT)

Table 100. Middle East and Africa Intravenous (IV) Ibuprofen Sales by Application (2023-2028) & (MT)

Table 101. Middle East and Africa Intravenous (IV) Ibuprofen Revenue by Application (2017-2022) & (US$ Million)

Table 102. Middle East and Africa Intravenous (IV) Ibuprofen Revenue by Application (2023-2028) & (US$ Million)

Table 103. Middle East and Africa Intravenous (IV) Ibuprofen Sales by Country (2017-2022) & (MT)

Table 104. Middle East and Africa Intravenous (IV) Ibuprofen Sales by Country (2023-2028) & (MT)

Table 105. Middle East and Africa Intravenous (IV) Ibuprofen Revenue by Country (2017-2022) & (US$ Million)

Table 106. Middle East and Africa Intravenous (IV) Ibuprofen Revenue by Country (2023-2028) & (US$ Million)

Table 107. Cumberland Pharmaceuticals Corporation Information

Table 108. Cumberland Pharmaceuticals Description and Major Businesses

Table 109. Cumberland Pharmaceuticals Intravenous (IV) Ibuprofen Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)

Table 110. Cumberland Pharmaceuticals Intravenous (IV) Ibuprofen Product Model Numbers, Pictures, Descriptions and Specifications

Table 111. Cumberland Pharmaceuticals Recent Developments

Table 112. Alveda Pharmaceuticals Corporation Information

Table 113. Alveda Pharmaceuticals Description and Major Businesses

Table 114. Alveda Pharmaceuticals Intravenous (IV) Ibuprofen Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)

Table 115. Alveda Pharmaceuticals Intravenous (IV) Ibuprofen Product Model Numbers, Pictures, Descriptions and Specifications

Table 116. Alveda Pharmaceuticals Recent Developments

Table 117. CSL Limited Corporation Information

Table 118. CSL Limited Description and Major Businesses

Table 119. CSL Limited Intravenous (IV) Ibuprofen Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)

Table 120. CSL Limited Intravenous (IV) Ibuprofen Product Model Numbers, Pictures, Descriptions and Specifications

Table 121. CSL Limited Recent Developments

Table 122. Sandor Medicaids Corporation Information

Table 123. Sandor Medicaids Description and Major Businesses

Table 124. Sandor Medicaids Intravenous (IV) Ibuprofen Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)

Table 125. Sandor Medicaids Intravenous (IV) Ibuprofen Product Model Numbers, Pictures, Descriptions and Specifications

Table 126. Sandor Medicaids Recent Developments

Table 127. PT. Soho Industri Pharmasi Corporation Information

Table 128. PT. Soho Industri Pharmasi Description and Major Businesses

Table 129. PT. Soho Industri Pharmasi Intravenous (IV) Ibuprofen Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)

Table 130. PT. Soho Industri Pharmasi Intravenous (IV) Ibuprofen Product Model Numbers, Pictures, Descriptions and Specifications

Table 131. PT. Soho Industri Pharmasi Recent Developments

Table 132. Germin MED Corporation Information

Table 133. Germin MED Description and Major Businesses

Table 134. Germin MED Intravenous (IV) Ibuprofen Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)

Table 135. Germin MED Intravenous (IV) Ibuprofen Product Model Numbers, Pictures, Descriptions and Specifications

Table 136. Germin MED Recent Developments

Table 137. Grifols Corporation Information

Table 138. Grifols Description and Major Businesses

Table 139. Grifols Intravenous (IV) Ibuprofen Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)

Table 140. Grifols Intravenous (IV) Ibuprofen Product Model Numbers, Pictures, Descriptions and Specifications

Table 141. Grifols Recent Developments

Table 142. Gloria Pharmaceuticals Corporation Information

Table 143. Gloria Pharmaceuticals Description and Major Businesses

Table 144. Gloria Pharmaceuticals Intravenous (IV) Ibuprofen Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)

Table 145. Gloria Pharmaceuticals Intravenous (IV) Ibuprofen Product Model Numbers, Pictures, Descriptions and Specifications

Table 146. Gloria Pharmaceuticals Recent Developments

Table 147. Al Nabeel International Corporation Information

Table 148. Al Nabeel International Description and Major Businesses

Table 149. Al Nabeel International Intravenous (IV) Ibuprofen Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)

Table 150. Al Nabeel International Intravenous (IV) Ibuprofen Product Model Numbers, Pictures, Descriptions and Specifications

Table 151. Al Nabeel International Recent Developments

Table 152. Laboratorios Valmorca Corporation Information

Table 153. Laboratorios Valmorca Description and Major Businesses

Table 154. Laboratorios Valmorca Intravenous (IV) Ibuprofen Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)

Table 155. Laboratorios Valmorca Intravenous (IV) Ibuprofen Product Model Numbers, Pictures, Descriptions and Specifications

Table 156. Laboratorios Valmorca Recent Developments

Table 157. Key Raw Materials Lists

Table 158. Raw Materials Key Suppliers Lists

Table 159. Intravenous (IV) Ibuprofen Distributors List

Table 160. Intravenous (IV) Ibuprofen Customers List

Table 161. Intravenous (IV) Ibuprofen Market Trends

Table 162. Intravenous (IV) Ibuprofen Market Drivers

Table 163. Intravenous (IV) Ibuprofen Market Challenges

Table 164. Intravenous (IV) Ibuprofen Market Restraints

Table 165. Research Programs/Design for This Report

Table 166. Key Data Information from Secondary Sources

Table 167. Key Data Information from Primary Sources

List of Figures

Figure 1. Intravenous (IV) Ibuprofen Product Picture

Figure 3. Global Intravenous (IV) Ibuprofen Market Share by Type in 2021 & 2028

Figure 3. 100 mg Dose Product Picture

Figure 4. 200 mg Dose Product Picture

Figure 5. 400 mg Dose Product Picture

Figure 6. 800 mg Dose Product Picture

Figure 7. Global Intravenous (IV) Ibuprofen Market Share by Application in 2021 & 2028

Figure 8. Pain

Figure 9. Fever

Figure 10. Inflammation

Figure 11. Intravenous (IV) Ibuprofen Report Years Considered

Figure 12. Global Intravenous (IV) Ibuprofen Sales 2017-2028 (MT)

Figure 13. Global Intravenous (IV) Ibuprofen Revenue, (US$ Million), 2017 VS 2021 VS 2028

Figure 14. Global Intravenous (IV) Ibuprofen Revenue 2017-2028 (US$ Million)

Figure 15. Global Intravenous (IV) Ibuprofen Revenue Market Share by Region in Percentage: 2021 Versus 2028

Figure 16. Global Intravenous (IV) Ibuprofen Sales Market Share by Region (2017-2022)

Figure 17. Global Intravenous (IV) Ibuprofen Sales Market Share by Region (2023-2028)

Figure 18. North America Intravenous (IV) Ibuprofen Sales YoY (2017-2028) & (MT)

Figure 19. North America Intravenous (IV) Ibuprofen Revenue YoY (2017-2028) & (US$ Million)

Figure 20. Europe Intravenous (IV) Ibuprofen Sales YoY (2017-2028) & (MT)

Figure 21. Europe Intravenous (IV) Ibuprofen Revenue YoY (2017-2028) & (US$ Million)

Figure 22. Asia-Pacific Intravenous (IV) Ibuprofen Sales YoY (2017-2028) & (MT)

Figure 23. Asia-Pacific Intravenous (IV) Ibuprofen Revenue YoY (2017-2028) & (US$ Million)

Figure 24. Latin America Intravenous (IV) Ibuprofen Sales YoY (2017-2028) & (MT)

Figure 25. Latin America Intravenous (IV) Ibuprofen Revenue YoY (2017-2028) & (US$ Million)

Figure 26. Middle East & Africa Intravenous (IV) Ibuprofen Sales YoY (2017-2028) & (MT)

Figure 27. Middle East & Africa Intravenous (IV) Ibuprofen Revenue YoY (2017-2028) & (US$ Million)

Figure 28. The Intravenous (IV) Ibuprofen Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021

Figure 29. The Top 5 and 10 Largest Manufacturers of Intravenous (IV) Ibuprofen in the World: Market Share by Intravenous (IV) Ibuprofen Revenue in 2021

Figure 30. Global Intravenous (IV) Ibuprofen Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021

Figure 31. Global Intravenous (IV) Ibuprofen Sales Market Share by Type (2017-2028)

Figure 32. Global Intravenous (IV) Ibuprofen Revenue Market Share by Type (2017-2028)

Figure 33. Global Intravenous (IV) Ibuprofen Sales Market Share by Application (2017-2028)

Figure 34. Global Intravenous (IV) Ibuprofen Revenue Market Share by Application (2017-2028)

Figure 35. North America Intravenous (IV) Ibuprofen Sales Market Share by Type (2017-2028)

Figure 36. North America Intravenous (IV) Ibuprofen Revenue Market Share by Type (2017-2028)

Figure 37. North America Intravenous (IV) Ibuprofen Sales Market Share by Application (2017-2028)

Figure 38. North America Intravenous (IV) Ibuprofen Revenue Market Share by Application (2017-2028)

Figure 39. North America Intravenous (IV) Ibuprofen Sales Share by Country (2017-2028)

Figure 40. North America Intravenous (IV) Ibuprofen Revenue Share by Country (2017-2028)

Figure 41. U.S. Intravenous (IV) Ibuprofen Revenue (2017-2028) & (US$ Million)

Figure 42. Canada Intravenous (IV) Ibuprofen Revenue (2017-2028) & (US$ Million)

Figure 43. Europe Intravenous (IV) Ibuprofen Sales Market Share by Type (2017-2028)

Figure 44. Europe Intravenous (IV) Ibuprofen Revenue Market Share by Type (2017-2028)

Figure 45. Europe Intravenous (IV) Ibuprofen Sales Market Share by Application (2017-2028)

Figure 46. Europe Intravenous (IV) Ibuprofen Revenue Market Share by Application (2017-2028)

Figure 47. Europe Intravenous (IV) Ibuprofen Sales Share by Country (2017-2028)

Figure 48. Europe Intravenous (IV) Ibuprofen Revenue Share by Country (2017-2028)

Figure 49. Germany Intravenous (IV) Ibuprofen Revenue (2017-2028) & (US$ Million)

Figure 50. France Intravenous (IV) Ibuprofen Revenue (2017-2028) & (US$ Million)

Figure 51. U.K. Intravenous (IV) Ibuprofen Revenue (2017-2028) & (US$ Million)

Figure 52. Italy Intravenous (IV) Ibuprofen Revenue (2017-2028) & (US$ Million)

Figure 53. Russia Intravenous (IV) Ibuprofen Revenue (2017-2028) & (US$ Million)

Figure 54. Asia Pacific Intravenous (IV) Ibuprofen Sales Market Share by Type (2017-2028)

Figure 55. Asia Pacific Intravenous (IV) Ibuprofen Revenue Market Share by Type (2017-2028)

Figure 56. Asia Pacific Intravenous (IV) Ibuprofen Sales Market Share by Application (2017-2028)

Figure 57. Asia Pacific Intravenous (IV) Ibuprofen Revenue Market Share by Application (2017-2028)

Figure 58. Asia Pacific Intravenous (IV) Ibuprofen Sales Share by Region (2017-2028)

Figure 59. Asia Pacific Intravenous (IV) Ibuprofen Revenue Share by Region (2017-2028)

Figure 60. China Intravenous (IV) Ibuprofen Revenue (2017-2028) & (US$ Million)

Figure 61. Japan Intravenous (IV) Ibuprofen Revenue (2017-2028) & (US$ Million)

Figure 62. South Korea Intravenous (IV) Ibuprofen Revenue (2017-2028) & (US$ Million)

Figure 63. India Intravenous (IV) Ibuprofen Revenue (2017-2028) & (US$ Million)

Figure 64. Australia Intravenous (IV) Ibuprofen Revenue (2017-2028) & (US$ Million)

Figure 65. Taiwan Intravenous (IV) Ibuprofen Revenue (2017-2028) & (US$ Million)

Figure 66. Indonesia Intravenous (IV) Ibuprofen Revenue (2017-2028) & (US$ Million)

Figure 67. Thailand Intravenous (IV) Ibuprofen Revenue (2017-2028) & (US$ Million)

Figure 68. Malaysia Intravenous (IV) Ibuprofen Revenue (2017-2028) & (US$ Million)

Figure 69. Philippines Intravenous (IV) Ibuprofen Revenue (2017-2028) & (US$ Million)

Figure 70. Latin America Intravenous (IV) Ibuprofen Sales Market Share by Type (2017-2028)

Figure 71. Latin America Intravenous (IV) Ibuprofen Revenue Market Share by Type (2017-2028)

Figure 72. Latin America Intravenous (IV) Ibuprofen Sales Market Share by Application (2017-2028)

Figure 73. Latin America Intravenous (IV) Ibuprofen Revenue Market Share by Application (2017-2028)

Figure 74. Latin America Intravenous (IV) Ibuprofen Sales Share by Country (2017-2028)

Figure 75. Latin America Intravenous (IV) Ibuprofen Revenue Share by Country (2017-2028)

Figure 76. Mexico Intravenous (IV) Ibuprofen Revenue (2017-2028) & (US$ Million)

Figure 77. Brazil Intravenous (IV) Ibuprofen Revenue (2017-2028) & (US$ Million)

Figure 78. Argentina Intravenous (IV) Ibuprofen Revenue (2017-2028) & (US$ Million)

Figure 79. Middle East and Africa Intravenous (IV) Ibuprofen Sales Market Share by Type (2017-2028)

Figure 80. Middle East and Africa Intravenous (IV) Ibuprofen Revenue Market Share by Type (2017-2028)

Figure 81. Middle East and Africa Intravenous (IV) Ibuprofen Sales Market Share by Application (2017-2028)

Figure 82. Middle East and Africa Intravenous (IV) Ibuprofen Revenue Market Share by Application (2017-2028)

Figure 83. Middle East and Africa Intravenous (IV) Ibuprofen Sales Share by Country (2017-2028)

Figure 84. Middle East and Africa Intravenous (IV) Ibuprofen Revenue Share by Country (2017-2028)

Figure 85. Turkey Intravenous (IV) Ibuprofen Revenue (2017-2028) & (US$ Million)

Figure 86. Saudi Arabia Intravenous (IV) Ibuprofen Revenue (2017-2028) & (US$ Million)

Figure 87. U.A.E Intravenous (IV) Ibuprofen Revenue (2017-2028) & (US$ Million)

Figure 88. Intravenous (IV) Ibuprofen Value Chain

Figure 89. Intravenous (IV) Ibuprofen Production Process

Figure 90. Channels of Distribution

Figure 91. Distributors Profiles

Figure 92. Bottom-up and Top-down Approaches for This Report

Figure 93. Data Triangulation

Figure 94. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

Ibuprofen Market

Global Intravenous (IV) Ibuprofen Market Insights and Forecast to 2028

Published Date: January 2022

Report Code: QYRE-Auto-33Q3518

Global Intravenous (IV) Ibuprofen Market Insights and Forecast to 2028

FEATURED COMPANIES

Intravenous (IV) Ibuprofen Market Analysis - 2028

Intravenous (IV) Ibuprofen Market Segment Review

Intravenous (IV) Ibuprofen Market by Type

Intravenous (IV) Ibuprofen Market by Application

Major Players in the Intravenous (IV) Ibuprofen Market

Intravenous (IV) Ibuprofen Market by Region

Intravenous (IV) Ibuprofen Market Report Coverage

Frequently Asked Questions About This Report

1. What is the current size of the global Intravenous (IV) Ibuprofen Market?

2. Who are the major companies in the Intravenous (IV) Ibuprofen Market?

3. What would be the forecast period in the Intravenous (IV) Ibuprofen Market report?

4. How can I get sample report/company profiles of the global Intravenous (IV) Ibuprofen industry?

FEATURED COMPANIES